Jump Financial’s Pacira BioSciences PCRX Stock Holding History

Jump Financial’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$307K	Buy	+12,100	New	+$286K	﹤0.01%	1671
2025 Q4	–	Sell	-20,458	Closed	-$527K	–	2204
2025 Q3	$527K	Buy	+20,458	New	+$502K	0.01%	1268
2024 Q4	–	Sell	-152,609	Closed	-$2.3M	–	1913
2024 Q3	$2.3M	Buy	152,609 +140,309	+1,141%	+$2.4M	0.05%	466
2024 Q2	$352K	Sell	12,300 -27,969	-69%	-$796K	0.01%	1311
2024 Q1	$1.18M	Buy	40,269 +969	+2%	+$29.8K	0.03%	716
2023 Q4	$1.33M	Sell	39,300 -19,573	-33%	-$573K	0.04%	564
2023 Q3	$1.81M	Buy	58,873 +47,173	+403%	+$1.7M	0.07%	412
2023 Q2	$469K	Buy	+11,700	New	+$484K	0.02%	1061
2023 Q1	–	Sell	-35,382	Closed	-$1.37M	–	1945
2022 Q4	$1.37M	Buy	+35,382	New	+$1.72M	0.07%	367
2022 Q1	–	Sell	-6,463	Closed	-$389K	–	1817
2021 Q4	$389K	Buy	+6,463	New	+$356K	0.02%	772
2021 Q3	–	Sell	-24,685	Closed	-$1.5M	–	1403
2021 Q2	$1.5M	Buy	+24,685	New	+$1.56M	0.14%	176

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jump Financial's PCRX Position: Q2 2026 in Review

Jump Financial opened a new position in Pacira BioSciences (PCRX) in Q2 2026: 12,100 shares worth $307K. The stake represents ﹤0.01% of the portfolio and ranks #1671 among its holdings. This is a return to the name: Jump Financial previously reported a position in PCRX as recently as Q3 2025.

Jump Financial first reported a position in PCRX in Q2 2021 and has held it in 11 quarters since. The position peaked at $2.3M in Q3 2024. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Jump Financial held 12,100 shares of Pacira BioSciences worth $307K as of Q2 2026.
Pacira BioSciences was a new Jump Financial position in Q2 2026.
Pacira BioSciences made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1671 holding.
Jump Financial first reported a position in Pacira BioSciences in Q2 2021 and has held it in 11 quarters since.
Jump Financial's Pacira BioSciences position peaked at $2.3M in Q3 2024.
254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.